Guilin Pharmaceutical Co.,Ltd.
As of 18 November 2026, for the company name Guilin Pharmaceutical Co.,Ltd. as recorded, the chemical-drug catalogue lists 24 active records with this name as holder; 35 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
41 acceptance records as first applicant, grouped into 28 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Dotinurad Tablets 2 records · Latest accepted 2026/05/12
Generic · 2
Pemafibrate Tablets 1 records · Latest accepted 2026/04/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600973 | Generic | 2026/04/28 | Guilin Pharmaceutical Co.,Ltd.; Beijing Yi Ling Bio Gong Cheng Technology Co., Ltd. romanized | CDE ↗ |
利伐沙班干混悬剂 · No verified English name 2 records · Latest accepted 2025/09/28
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501928 | Supplement | 2025/09/28 | Guilin Pharmaceutical Co.,Ltd.; Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2501927 | Supplement | 2025/09/28 | Guilin Pharmaceutical Co.,Ltd.; Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Baloxavir Marboxil Tablets 1 records · Latest accepted 2025/07/23
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501471 | Supplement | 2025/07/23 | Guilin Pharmaceutical Co.,Ltd.; Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Bilastine Tablets 1 records · Latest accepted 2025/03/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501203 | Generic | 2025/03/28 | Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
Josamycin Tablets 1 records · Latest accepted 2025/02/28
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2550128 | Supplement | 2025/02/28 | Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
Aspirin Enteric-coated Tablets 6 records · Latest accepted 2025/02/09
Supplement · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2500265 | Supplement | 2025/02/09 | Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHB2500264 | Supplement | 2025/02/09 | Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHB2500263 | Supplement | 2025/02/09 | Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHB2350319 | Supplement | 2023/04/06 | Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHB2150675 | Supplement | 2021/06/18 | Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHB2150112 | Supplement | 2021/02/09 | Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
Polymyxin B sulfate for Injection 1 records · Latest accepted 2025/01/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500394 | Generic | 2025/01/22 | Guilin Pharmaceutical Co.,Ltd.; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
Isavuconazonium Sulfate for Injection 1 records · Latest accepted 2025/01/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500348 | Generic | 2025/01/17 | Guilin Pharmaceutical Co.,Ltd.; Suzhou Erye Pharmaceutical Co., Ltd | CDE ↗ |
Azilsartan Medoxomil Potassium Tablets 2 records · Latest accepted 2024/12/18
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2402162 | Supplement | 2024/12/18 | Guilin Pharmaceutical Co.,Ltd.; Shandong Loncom Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2402161 | Supplement | 2024/12/18 | Guilin Pharmaceutical Co.,Ltd.; Shandong Loncom Pharmaceutical Co., Ltd. | CDE ↗ |
维生素B?注射液 · No verified English name 1 records · Latest accepted 2024/11/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450560 | Supplement | 2024/11/09 | Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
马立巴韦片 · No verified English name 1 records · Latest accepted 2024/10/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403523 | Generic | 2024/10/18 | Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
神曲胃痛片 · No verified English name 1 records · Latest accepted 2024/10/15
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2401967 | Supplement | 2024/10/15 | Guilin Pharmaceutical Co.,Ltd.; Hebei Wan Bang Fu Lin Pharma Co., Ltd. romanized | CDE ↗ |
Ethyl Iosapentate Capsules 1 records · Latest accepted 2024/09/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403262 | Generic | 2024/09/26 | Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
青蒿琥酯片 · No verified English name 3 records · Latest accepted 2024/05/25
New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2400527 | New drug | 2024/05/25 | Guilin Pharmaceutical Co.,Ltd.; Shanghai Jiao Tong University romanized | CDE ↗ |
| CXHL2300710 | New drug | 2023/06/28 | Guilin Pharmaceutical Co.,Ltd.; Shanghai Jiao Tong University romanized | CDE ↗ |
| CXHL2101826 | New drug | 2021/12/28 | Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
Foscarnet Sodium Injection 1 records · Latest accepted 2024/04/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401132 | Generic | 2024/04/17 | Guilin Pharmaceutical Co.,Ltd.; Chi Feng Yuan Sheng Pharma Co., Ltd. romanized | CDE ↗ |
Peramivir Injection 1 records · Latest accepted 2023/08/15
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301799 | Supplement | 2023/08/15 | Guilin Pharmaceutical Co.,Ltd.; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Dopamine Hydrochloride Injection 1 records · Latest accepted 2023/06/28
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301404 | Supplement | 2023/06/28 | Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
Bumetanide Injection 2 records · Latest accepted 2023/03/10
Supplement · 2
Tedizolid Phosphate Tablets 1 records · Latest accepted 2023/01/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300180 | Generic | 2023/01/19 | Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
泊沙康唑注射液 · No verified English name 1 records · Latest accepted 2023/01/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300135 | Generic | 2023/01/13 | Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
Avatrombopag Maleate Tablets 1 records · Latest accepted 2023/01/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300116 | Generic | 2023/01/12 | Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
Tolvaptan Tablets 1 records · Latest accepted 2022/09/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201625 | Supplement | 2022/09/09 | Guilin Pharmaceutical Co.,Ltd.; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
阿普米司特片 · No verified English name 3 records · Latest accepted 2022/09/09
Generic · 3
Amiodarone Hydrochloride Injection 1 records · Latest accepted 2022/09/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201486 | Generic | 2022/09/08 | Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
Sertraline Hydrochloride Tablets 1 records · Latest accepted 2022/07/05
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201011 | Generic | 2022/07/05 | Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
氯化钠注射液 · No verified English name 1 records · Latest accepted 2022/01/05
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2200010 | Supplement | 2022/01/05 | Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
阿普斯特片 · No verified English name 1 records · Latest accepted 2021/05/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101190 | Generic | 2021/05/21 | Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
Changes in the last 90 days
2 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Marketing application approved: 1 applicationNo longer listed under review: 1 application
- 2026/11/10Marketing application approved
Polymyxin B sulfate for Injection
CYHS2500394 · 国药准字H20266537
Fact date: 2026/11/10 · Publication date: 2026/11/13 · Date added to this site: 2026/11/14
View source · Table row 44 ↗ - 2026/10/24No longer listed under review
Polymyxin B sulfate for Injection
CYHS2500394
Fact date: 2026/10/24 · Date added to this site: 2026/10/24
Accepted: 2025/01/22
no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/11/13 (approval no.: 国药准字H20266537; approval date: 2026/11/10) · NMPA source · row 44
NMPA · Table row 44 ↗ View source ↗
Under review
3 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Dotinurad Tablets | CYHS2601088 | Generic | 2026/05/12 | Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
| Dotinurad Tablets | CYHS2601087 | Generic | 2026/05/12 | Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
| Pemafibrate Tablets | CYHS2600973 | Generic | 2026/04/28 | Guilin Pharmaceutical Co.,Ltd.; Beijing Yi Ling Bio Gong Cheng Technology Co., Ltd. romanized | CDE ↗ |
Catalogue holder records
24 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Isavuconazonium Sulfate for Injection | Guilin Pharmaceutical Co.,Ltd. | Suzhou Erye Pharmaceutical Co., Ltd | 国药准字H20265952 | 2026/09/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ethyl Iosapentate Capsules | Guilin Pharmaceutical Co.,Ltd. | Guilin Pharmaceutical Co.,Ltd. | 国药准字H20264546 | 2026/05/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 马立巴韦片 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Guilin Pharmaceutical Co.,Ltd. | 国药准字H20264342 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 维生素B6注射液 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Guilin Pharmaceutical Co.,Ltd. | 国药准字H20269050 | 2026/03/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 利伐沙班干混悬剂 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | 国药准字H20256098 | 2025/12/03 | Not stated by source | CDE ↗ |
| 利伐沙班干混悬剂 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | 国药准字H20256099 | 2025/12/03 | Not stated by source | CDE ↗ |
| Foscarnet Sodium Injection | Guilin Pharmaceutical Co.,Ltd. | Chi Feng Yuan Sheng Pharma Co., Ltd. romanized | 国药准字H20256094 | 2025/12/03 | Not stated by source | CDE ↗ |
| Azilsartan Medoxomil Potassium Tablets | Guilin Pharmaceutical Co.,Ltd. | Shandong Loncom Pharmaceutical Co., Ltd. | 国药准字H20253641 | 2025/03/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Azilsartan Medoxomil Potassium Tablets | Guilin Pharmaceutical Co.,Ltd. | Shandong Loncom Pharmaceutical Co., Ltd. | 国药准字H20253642 | 2025/03/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 泊沙康唑注射液 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Guilin Pharmaceutical Co.,Ltd. | 国药准字H20244655 | 2024/08/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tedizolid Phosphate Tablets | Guilin Pharmaceutical Co.,Ltd. | Guilin Pharmaceutical Co.,Ltd. | 国药准字H20243940 | 2024/06/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 阿普米司特片 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Guilin Pharmaceutical Co.,Ltd. | 国药准字H20243679 | 2024/05/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 阿普米司特片 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Guilin Pharmaceutical Co.,Ltd. | 国药准字H20243681 | 2024/05/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sertraline Hydrochloride Tablets | Guilin Pharmaceutical Co.,Ltd. | Guilin Pharmaceutical Co.,Ltd. | 国药准字H20243683 | 2024/05/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 阿普米司特片 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Guilin Pharmaceutical Co.,Ltd. | 国药准字H20243680 | 2024/05/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Amiodarone Hydrochloride Injection | Guilin Pharmaceutical Co.,Ltd. | Guilin Pharmaceutical Co.,Ltd. | 国药准字H20243507 | 2024/04/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bumetanide Injection | Guilin Pharmaceutical Co.,Ltd. | Guilin Pharmaceutical Co.,Ltd. | 国药准字H20057225 | 2024/04/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Bumetanide Injection | Guilin Pharmaceutical Co.,Ltd. | Guilin Pharmaceutical Co.,Ltd. | 国药准字H20247066 | 2024/04/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Aspirin Enteric-coated Tablets | Guilin Pharmaceutical Co.,Ltd. | Guilin Pharmaceutical Co.,Ltd. | 国药准字H20237116 | 2023/09/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Roxithromycin Tablets | Guilin Pharmaceutical Co.,Ltd. | Guilin Pharmaceutical Co.,Ltd. | 国药准字H10970396 | 2021/11/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Moxifloxacin Hydrochloride Tablets | Guilin Pharmaceutical Co.,Ltd. | Guilin Pharmaceutical Co.,Ltd. | 国药准字H20213851 | 2021/11/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Metronidazole Tablets | Guilin Pharmaceutical Co.,Ltd. | Guilin Pharmaceutical Co.,Ltd. | 国药准字H45020818 | 2021/06/08 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Linezolid Tablets | Guilin Pharmaceutical Co.,Ltd. | Guilin Pharmaceutical Co.,Ltd. | 国药准字H20213096 | 2021/02/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Avatrombopag Maleate Tablets | Guilin Pharmaceutical Co.,Ltd. | Guilin Pharmaceutical Co.,Ltd. | 国药准字H20244398 | 2024/07/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
35 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 托伐普坦磷酸钠 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20250001046 | I | 2025/10/13 | CDE ↗ |
| 托伐普坦 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20250000674 | I | 2025/07/14 | CDE ↗ |
| 马立巴韦 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20240000993 | A | 2026/08/19 | CDE ↗ |
| 布立西坦 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20240000394 | I | 2025/10/27 | CDE ↗ |
| 泊沙康唑 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20230001346 | A | 2025/07/18 | CDE ↗ |
| 马来酸阿伐曲泊帕 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20220001118 | A | 2025/05/29 | CDE ↗ |
| 乙胺嘧啶 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20190009804 | A | — | CDE ↗ |
| 磺胺多辛 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20190009802 | A | — | CDE ↗ |
| 氟氯西林钠 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20190008283 | A | 2025/01/18 | CDE ↗ |
| 蒿甲醚 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20190007417 | A | 2025/01/18 | CDE ↗ |
| 双氢青蒿素 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20190006672 | A | 2025/01/18 | CDE ↗ |
| 本芴醇 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20190005891 | A | 2025/01/18 | CDE ↗ |
| 盐酸阿莫地喹 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20190004856 | A | 2025/01/18 | CDE ↗ |
| 联苯双酯 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20190004305 | A | 2025/01/24 | CDE ↗ |
| 诺氟沙星 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20190004304 | A | 2025/01/24 | CDE ↗ |
| 甲硝唑 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20190004293 | A | 2025/01/18 | CDE ↗ |
| 西洛他唑 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20190004271 | A | 2025/01/24 | CDE ↗ |
| 牛磺酸 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20190004267 | A | 2025/01/24 | CDE ↗ |
| 盐酸左旋咪唑 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20190004104 | A | 2025/01/18 | CDE ↗ |
| 青蒿琥酯 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20190004097 | A | 2025/01/18 | CDE ↗ |
| 盐酸胍甲环素 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20190004094 | A | 2025/01/18 | CDE ↗ |
| 乳酶生 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20190004093 | A | 2025/01/18 | CDE ↗ |
| 细辛脑 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20190004092 | A | 2025/01/18 | CDE ↗ |
| 阿苯达唑 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20190004091 | A | 2025/01/18 | CDE ↗ |
| 布美他尼 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20190004090 | A | 2025/01/18 | CDE ↗ |
| 罗红霉素 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20190004088 | A | 2025/01/18 | CDE ↗ |
| 硫酸亚铁 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20190004085 | A | 2025/01/18 | CDE ↗ |
| 鲑降钙素 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20190004083 | A | 2025/01/18 | CDE ↗ |
| 甲苯咪唑 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20190004065 | A | 2025/01/18 | CDE ↗ |
| 利奈唑胺 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20180000159 | A | 2025/11/15 | CDE ↗ |
| 盐酸莫西沙星 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20170002212 | A | 2025/11/15 | CDE ↗ |
| 磺胺多辛 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20170001900 | A | 2025/01/18 | CDE ↗ |
| 乙胺嘧啶 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20170001899 | A | 2025/01/18 | CDE ↗ |
| 磷酸哌喹 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20170001277 | I | — | CDE ↗ |
| 萘夫西林钠 · No verified English name | Guilin Pharmaceutical Co.,Ltd. | Y20170000332 | I | — | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
5 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Edaravone and Dexborneol Concentrated Solution for Injection | CYHS2600760 | Generic | 2026/04/01 | Shandong Bai Nuo Pharmaceuticals Co., Ltd. romanized; Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
| Avatrombopag Maleate Tablets | CYHB2500327 | Supplement | 2025/02/18 | Guangxi Nanning Baihui Pharmaceutical Group Co.,Ltd.; Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
| Aspirin Enteric-coated Tablets | CYHB2400424 | Supplement | 2024/03/26 | Chongqing Heng Xin Bio Technology Kai Fa Co., Ltd. romanized; Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
| Aspirin Enteric-coated Tablets | CYHB2400423 | Supplement | 2024/03/26 | Chongqing Heng Xin Bio Technology Kai Fa Co., Ltd. romanized; Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
| Aspirin Enteric-coated Tablets | CYHB2400422 | Supplement | 2024/03/26 | Chongqing Heng Xin Bio Technology Kai Fa Co., Ltd. romanized; Guilin Pharmaceutical Co.,Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.